At baseline, mean age was 45 years (range 18 to 78), 79% were female, 85% were White, 10% were Black or African American, and 11% were Hispanic/Latino Ethnicity
Overall, we see real potential for GLP-1 and oral health to align in a positive direction
Click here to book your PT-141 consultation at RECOVERY PROJECT and let our physician-guided team help you decide if PT-141 peptide therapy is right for you
Qualitatively, both self-report and EHR data showed similar distributions for weight loss efficacy (Extended Data Fig
STEP 1 reported nausea in 44% of patients, vomiting in 24%, and diarrhea in 31% on 2.4 mg semaglutide
[PMID: 2590167] PubMed record related to this compound for laboratory literature review